Browsing: Reiterates

Salesforce (NYSE:CRM – Get Free Report)’s stock had its “market outperform” rating reiterated by equities research analysts at Citizens Jmp in a report released on Friday, Benzinga reports. They presently have a $315.00 target price on the CRM provider’s stock. Citizens Jmp’s target price points to a potential upside of 29.44% from the company’s current…

Salesforce (NYSE:CRM – Get Free Report)’s stock had its “overweight” rating reaffirmed by equities researchers at Cantor Fitzgerald in a research note issued to investors on Thursday,Benzinga reports. They currently have a $250.00 price objective on the CRM provider’s stock. Cantor Fitzgerald’s price target suggests a potential upside of 21.41% from the company’s current price.